Doug Lass Forsha, MD
Dermatology · West Jordan, UTNPI 1285674671
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $160,301 of the $212,915 with a category attached, or 75.3%. 31 manufacturers reported payments, led by UCB, Inc. at 56.7% of the total. Among dermatology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,072 payments — averaging $198.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$121K
- Pfizer$45K
- Dermira, Inc.$14K
- Amgen$11K
- LEO Pharma Inc.$5K
- AbbVie$4K
- plus $13K from 25 others
Across 402 payments — averaging $4955.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$1.1M
- Amgen$197K
- Eli Lilly$164K
- E.r. Squibb & Sons, L.L.C.$114K
- Pfizer$108K
- AbbVie$70K
- plus $232K from 10 others
What the payments were for
- Consulting fees$15,7747%
- Speaking & faculty fees$160,30175%
- Travel & lodging$14,4457%
- Food & beverage$22,18210%
- Education$2130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 200 | $120,751 |
| Pfizer | 140 | $45,251 |
| Dermira, Inc. | 14 | $14,099 |
| Amgen | 32 | $10,567 |
| LEO Pharma Inc. | 12 | $4,938 |
| AbbVie | 257 | $4,435 |
| Sun Pharmaceutical Industries Inc. | 44 | $3,923 |
| Galderma Laboratories, L.p. | 45 | $1,496 |
| Novartis | 41 | $1,292 |
| Dermavant Sciences, Inc. | 49 | $977 |
| Incyte Corporation | 49 | $970 |
| E.r. Squibb & Sons, L.L.C. | 16 | $693 |
| Johnson & Johnson | 24 | $651 |
| Arcutis Biotherapeutics, Inc. | 60 | $622 |
| Biofrontera Inc. | 18 | $449 |
| Lilly USA, LLC | 15 | $379 |
| Revance Therapeutics, Inc. | 3 | $332 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 18 | $329 |
| Regeneron Healthcare Solutions, Inc. | 8 | $221 |
| Sanofi | 6 | $92 |
| Janssen Scientific Affairs, LLC | 2 | $83 |
| Bristol Myers Squibb | 1 | $54 |
| EPI Health, LLC | 4 | $53 |
| VYNE Pharmaceuticals Inc. | 1 | $53 |
| AstraZeneca | 2 | $50 |
| Organon | 6 | $46 |
| Sanofi-aventis U.S. LLC | 1 | $31 |
| Almirall LLC | 1 | $28 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $21 |
| Mylan Institutional Inc. | 1 | $18 |
| Merck | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$212,915 in reported general payments places this provider in the 95th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 17 | $146,967 |
| Imiquimod | 78 | $2,673 |
| Clobetasol Propionate | 64 | $2,530 |
| Doxycycline Monohydrate | 125 | $2,264 |
| ValacyclovirValacyclovir Hcl | 30 | $1,272 |
| Fluconazole | 55 | $1,199 |
| Hydrocortisone | 28 | $1,135 |
| Famciclovir | 13 | $1,010 |
| Hydroxyzine Hcl | 16 | $899 |
| Minoxidil | 63 | $879 |
| Triamcinolone Acetonide | 42 | $798 |
| Dapsone | 12 | $702 |
| Cephalexin | 32 | $558 |
| Azithromycin | 18 | $160 |
| MethotrexateMethotrexate Sodium | 11 | $89 |
Paid to pharmacies, not to this prescriber.
Other dermatology in West Jordan
- Kimberly HuerthWest Jordan$6K
- Michael HinckleyWest Jordan$3K
- Brian WilliamsMidvale$876K
- Travis JamesProvidence$437K
- Jason HadleyBountiful$294K
- Gerald KruegerSalt Lake City$156K
- Jamie RhoadsMurray$105K
- Kristina DuffinSalt Lake City$89K
- Mark TaylorSalt Lake City$58K
- Lori RamirezKaysville$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.